The Z isomer of pyridoxilidenerhodanine 5′‐phosphate is an efficient inhibitor of human pyridoxine 5′‐phosphate oxidase, a crucial enzyme in vitamin B 6 salvage pathway and a potential chemotherapeutic target
The FEBS Journal · 2024
DOI: 10.1111/febs.17274 ↗Kurz gefasst
Fachartikel in der Zeitschrift The FEBS Journal, 2024. Verfasst von Claudio Graziani und 9 weiteren Autor:innen. Beteiligte Einrichtung: Dipartimento di Scienze Biochimiche "A. Rossi Fanelli", Sapienza Università di Roma, Italy. Hauptthemen laut MEDLINE: Pyridoxaminephosphate Oxidase, Vitamin B 6, Pyridoxal Phosphate. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 55 Literaturangaben. Gefördert von: Istituto Pasteur - Fondazione Cenci Bolognetti, European Union - NextGenerationEU, Sapienza Università di Roma.
Abstract (Originalsprache)
Pyridoxal 5′‐phosphate (PLP), the catalytically active form of vitamin B 6 , acts as a cofactor in many metabolic processes. In humans, PLP is produced in the reactions catalysed by pyridox(am)ine 5′‐phosphate oxidase (PNPO) and pyridoxal kinase (PDXK). Both PNPO and PDXK are involved in cancer progression of many tumours. The silencing of PNPO and PDXK encoding genes determines a strong reduction in tumour size and neoplastic cell invasiveness in models of acute myeloid leukaemia (in the case of PDXK) and ovarian and breast cancer (in the case of PNPO). In the present work, we demonstrate that pyridoxilidenerhodanine 5′‐phosphate (PLP‐R), a PLP analogue that has been tested by other authors on malignant cell lines reporting a reduction in proliferation, inhibits PNPO in vitro following a mixed competitive and allosteric mechanism. We also show that the unphosphorylated precursor of this inhibitor (PL‐R), which has more favourable pharmacokinetic properties according to our predictions, is phosphorylated by PDXK and therefore transformed into PLP‐R. On this ground, we propose the prototype of a novel prodrug‐drug system as a useful starting point for the development of new, potential, antineoplastic agents.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Dipartimento di Scienze Biochimiche "A. Rossi Fanelli", Sapienza Università di Roma, Italy.
- Istituto di Biologia e Patologia Molecolari, Consiglio Nazionale delle Ricerche, Rome, Italy.
- Dipartimento di Chimica, Sapienza Università di Roma, Italy.
- Istituto Pasteur Italia-Fondazione Cenci Bolognetti, Rome, Italy.
ORCID-Profile: Alessandro Paiardini, Angela Tramonti, Roberto Contestabile
Förderung
- Istituto Pasteur - Fondazione Cenci Bolognetti
- European Union - NextGenerationEU
- Sapienza Università di Roma
- Consiglio Nazionale delle Ricerche
- Istituto Pasteur-Fondazione Cenci Bolognetti
Zitieren
APA
Graziani, C., Barile, A., Antonelli, L., Fiorillo, A., Ilari, A., Vetica, F., di Salvo, M. L., Paiardini, A., Tramonti, A., & Contestabile, R. (2024). The Z isomer of pyridoxilidenerhodanine 5′‐phosphate is an efficient inhibitor of human pyridoxine 5′‐phosphate oxidase, a crucial enzyme in vitamin B 6 salvage pathway and a potential chemotherapeutic target. The FEBS Journal. https://doi.org/10.1111/febs.17274
Vancouver
Graziani C, Barile A, Antonelli L, Fiorillo A, Ilari A, Vetica F, et al. The Z isomer of pyridoxilidenerhodanine 5′‐phosphate is an efficient inhibitor of human pyridoxine 5′‐phosphate oxidase, a crucial enzyme in vitamin B 6 salvage pathway and a potential chemotherapeutic target. The FEBS Journal. 2024. doi:10.1111/febs.17274
BibTeX
@article{Graziani2024,
author = {Graziani, Claudio and Barile, Anna and Antonelli, Lorenzo and Fiorillo, Annarita and Ilari, Andrea and Vetica, Fabrizio and di Salvo, Martino Luigi and Paiardini, Alessandro and Tramonti, Angela and Contestabile, Roberto},
title = {The Z isomer of pyridoxilidenerhodanine 5′‐phosphate is an efficient inhibitor of human pyridoxine 5′‐phosphate oxidase, a crucial enzyme in vitamin B 6 salvage pathway and a potential chemotherapeutic target},
journal = {The FEBS Journal},
year = {2024},
doi = {10.1111/febs.17274}
}
EUVIMED